Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) insider Carmen Jeffrey Del sold 7,541 shares of the company’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $16.07, for a total transaction of $121,183.87. Following the completion of the sale, the insider now owns 18,427 shares of […]
Gallacher Capital Management LLC Has $245,000 Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Summit Global Investments Lowers Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Clark Estates Inc. NY bought a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 188,000 shares of the biopharmaceutical company’s stock, valued at approximately $2,198,000. Clark Estates Inc. NY owned 0.18% of Catalyst Pharmaceuticals […]
CenterBook Partners LP grew its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 20.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,577 shares of the biopharmaceutical company’s stock after acquiring an additional 2,259 shares during […]